Beskrivelse af Nordic Biotech Private Investors ApS
Representative Investments by Florian Schönharting
Role: Co-Founder
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and autoimmune diseases, based on proprietary next generation antibody technologies.
Ticker: GEN.CO - Market cap:
Din bedømmelse
Du skal give minimum én stjerne
Bedømmelse modtaget
Du vil inden for kort tid modtage en e-mail, hvori du kan bekræfte din bedømmelse.
Der er endnu ingen bedømmelser af denne virksomhed. Fortæl os om dine oplevelser!